Milton H. Werner
Chief Executive Officer, Inhibikase Therapeutics, Inc.
Companies
- Inhibikase Therapeutics, Inc.Board member Dec 22, 2020 to Jan 22, 20251
- Inhibikase Therapeutics, Inc.Chief executive officer Dec 22, 2020 to Jan 22, 20251
- Inhibikase Therapeutics, Inc.President Dec 22, 2020 to Jan 22, 20251
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Inhibikase Therapeutics, Inc. IKT5,359,022 shares2$8.4M at $1.57Aug 16, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 16, 2022Bought 5,000 shares at $0.80 of Inhibikase Therapeutics, Inc.2
- May 27, 2022Bought 5,000 shares at $0.98 of Inhibikase Therapeutics, Inc.3
- May 20, 2022Bought 10,000 shares at $0.60 of Inhibikase Therapeutics, Inc.4
- Jan 3, 2022Exercised options 21,853 shares at $2.02 of Inhibikase Therapeutics, Inc.5
- Nov 17, 2021Bought 400 shares at $1.93 of Inhibikase Therapeutics, Inc.6
- Nov 17, 2021Bought 1,334 shares at $1.94 of Inhibikase Therapeutics, Inc.6
- Nov 17, 2021Bought 3,186 shares at $1.96 of Inhibikase Therapeutics, Inc.6
- Nov 17, 2021Bought 1,100 shares at $1.97 of Inhibikase Therapeutics, Inc.6
- Nov 17, 2021Bought 17,569 shares at $1.98 of Inhibikase Therapeutics, Inc.6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed May 31, 2022
- 4SEC EDGARForm 4 filed May 23, 2022
- 5SEC EDGARForm 4 filed Jan 4, 2022
- 6SEC EDGARForm 4 filed Nov 19, 2021